These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16777385)

  • 1. Cost of depression: effect of adherence and treatment response.
    von Knorring L; Akerblad AC; Bengtsson F; Carlsson A; Ekselius L
    Eur Psychiatry; 2006 Sep; 21(6):349-54. PubMed ID: 16777385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of depression case management in small practices.
    Gensichen J; Petersen JJ; Von Korff M; Heider D; Baron S; König J; Freytag A; Krauth C; Gerlach FM; König HH
    Br J Psychiatry; 2013 Jun; 202():441-6. PubMed ID: 23580379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
    Leelahanaj T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
    Browne G; Steiner M; Roberts J; Gafni A; Byrne C; Dunn E; Bell B; Mills M; Chalklin L; Wallik D; Kraemer J
    J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.
    Pyne JM; Rost KM; Farahati F; Tripathi SP; Smith J; Williams DK; Fortney J; Coyne JC
    Psychol Med; 2005 Jun; 35(6):839-54. PubMed ID: 15997604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial compliance as determined from plasma levels of sertraline and its metabolite in depressed patients in primary care.
    Reis M; Akerblad AC; Ekselius L; von Knorring L
    J Clin Psychopharmacol; 2010 Dec; 30(6):746-8. PubMed ID: 21057244
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).
    Rubio-Valera M; Peñarrubia-María MT; Iglesias-González M; Knapp M; McCrone P; Roig M; Sabes-Figuera R; Luciano JV; Mendive JM; Murrugara-Centurión AG; Alonso J; Serrano-Blanco A
    Eur J Health Econ; 2019 Jul; 20(5):703-713. PubMed ID: 30725226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System.
    Lattanzio F; Cherubini A; Furneri G; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2008 Feb; 20(1):76-80. PubMed ID: 18283232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
    Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
    Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression.
    Von Korff M; Katon W; Bush T; Lin EH; Simon GE; Saunders K; Ludman E; Walker E; Unutzer J
    Psychosom Med; 1998; 60(2):143-9. PubMed ID: 9560861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the costs associated with depression and treatment noncompliance: the potential benefits of online support.
    Wade AG; Häring J
    Int Clin Psychopharmacol; 2010 Sep; 25(5):288-96. PubMed ID: 20715299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of a collaborative care intervention for major depressive disorder in an occupational healthcare setting.
    Goorden M; Vlasveld MC; Anema JR; van Mechelen W; Beekman AT; Hoedeman R; van der Feltz-Cornelis CM; Hakkaart-van Roijen L
    J Occup Rehabil; 2014 Sep; 24(3):555-62. PubMed ID: 24085535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.
    Maurizio B; Silvia M; Antonio C
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1083-5. PubMed ID: 17089109
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a minimal intervention for stress-related sick leave in general practice: results of an economic evaluation alongside a pragmatic randomised control trial.
    Uegaki K; Bakker I; de Bruijne M; van der Beek A; Terluin B; van Marwijk H; Heymans M; Stalman W; van Mechelen W
    J Affect Disord; 2010 Jan; 120(1-3):177-87. PubMed ID: 19439362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.